Early myocardial deformation abnormalities in breast cancer survivors

Breast Cancer Research and Treatment

Volumn 146, Issue 1, 2014, Pages 127-135

  Bulten, Ben F ^a   Mavinkurve Groothuis, Annelies M C ^a   De Geus Oei, Lioe Fee ^a   De Haan, Anton F J ^a   De Korte, Chris L ^a   Bellersen, Louise ^a   Van Laarhoven, Hanneke W M ^a,b   Kapusta, Livia ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

2D strain imaging; Anthracyclines; Biomarkers; Breast cancer; Echocardiography; Speckle tracking

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; HEMOGLOBIN A1C; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANTHRACYCLINE INDUCED CARDIOTOXICITY; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVOR; CARDIAC IMAGING; CARDIOTOXICITY; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; FEMALE; GLOBAL CIRCUMFERENTIAL MYOCARDIAL STRAIN; GLOBAL LONGITUDINAL MYOCARDIAL STRAIN; GLOBAL LONGITUDINAL MYOCARDIAL STRAIN RATE; GLOBAL RADIAL MYOCARDIAL STRAIN; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART VOLUME; HUMAN; MAJOR CLINICAL STUDY; MYOCARDIAL DISEASE; MYOCARDIAL STRAIN IMAGING; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; TWO DIMENSIONAL ECHOCARDIOGRAPHY; BREAST NEOPLASMS; CARDIOMYOPATHIES; COMPLICATION; ECHOCARDIOGRAPHY; HEART VENTRICLE FUNCTION; MIDDLE AGED; PATHOLOGY; SURVIVOR;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MIDDLE AGED; SURVIVORS; VENTRICULAR DYSFUNCTION;

EID: 84903726316     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2997-4     Document Type: Article

References (47)

1. Stoodley PW, Richards DA, Hui R, Boyd A, Harnett PR, Meikle SR, Clarke J, Thomas L (2011) Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy. Eur J Echocardiogr 12:945-952. doi:10.1093/ejechocard/jer187
2. Wouters KA, Kremer LC, Miller TL, Herman EH, Lipshultz SE (2005) Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies. Br J Haematol 131:561-578. doi:10.1111/j.1365-2141.2005. 05759.x (Pubitemid 43899624)
3. Chargari C, Kirov KM, Bollet MA, Magne N, Vedrine L, Cremades S, Beuzeboc P, Fourquet A, Kirova YM (2011) Cardiac toxicity in breast cancer patients: from a fractional point of view to a global assessment. Cancer Treat Rev 37:321-330. doi:10.1016/j.ctrv.2010.08.007
4. Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH (2007) Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25:3808-3815. doi:10.1200/JCO.2006. 10.4976 (Pubitemid 47477254)
5. Lipshultz SE, Lipsitz SR, Mone SM, Goorin AM, Sallan SE, Sanders SP, Orav EJ, Gelber RD, Colan SD (1995) Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 332:1556-1738
6. Gianni L, Herman EH, Lipshultz SE, Minotti G, Sarvazyan N, Sawyer DB (2008) Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol 26:3777-3784. doi:10.1200/JCO.2007.14.9401
7. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185-229. doi:10.1124/pr.56.2.6 (Pubitemid 38720829)
8. Yeh ET, Bickford CL (2009) Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol 53:2231-2247
9. Mavinkurve-Groothuis AM (2012) Anthracycline-induced cardiotoxicity. Early detection with new strategies. Radboud University, Nijmegen
10. Altena R, Perik PJ, van Veldhuisen DJ, de Vries EG, Gietema JA (2009) Cardiovascular toxicity caused by cancer treatment: strategies for early detection. Lancet Oncol 10:391-399. doi:10.1016/S1470-2045(09)70042-7
11. de Geus-Oei LF, Mavinkurve-Groothuis AM, Bellersen L, Gotthardt M, Oyen WJ, Kapusta L, van Laarhoven HW (2011) Scintigraphic techniques for early detection of cancer treatmentinduced cardiotoxicity. J Nucl Med 52:560-571. doi:10.2967/jnumed.110.082784
12. McGowan JH, Cleland JG (2003) Reliability of reporting left ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J 146:388-397. doi:10.1016/S0002-8703(03)00248-5 (Pubitemid 37083072)
13. Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popovic ZB, Marwick TH (2013) Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol 61:77-84. doi:10.1016/j.jacc.2012.09.035
14. Mavinkurve-Groothuis AM, Groot-Loonen J, Marcus KA, Bellersen L, Feuth T, Bokkerink JP, Hoogerbrugge PM, de Korte C, Kapusta L (2010) Myocardial strain and strain rate in monitoring subclinical heart failure in asymptomatic long-term survivors of childhood cancer. Ultrasound Med Biol 36:1783-1791. doi:10.1016/j.ultrasmedbio.2010.08.001
15. Jurcut R, Wildiers H, Ganame J, D'Hooge J, De Backer J, Denys H, Paridaens R, Rademakers F, Voigt JU (2008) Strain rate imaging detects early cardiac effects of pegylated liposomal doxorubicin as adjuvant therapy in elderly patients with breast cancer. J Am Soc Echocardiogr 21:1283-1289. doi:10.1016/j.echo.2008.10.005
16. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Tan TC, Cohen V, Banchs J, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M (2012) Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging 5:596-603. doi:10.1161/CIRCIMAGING.112.973321
17. Florescu M, Magda LS, Enescu OA, Jinga D, Vinereanu D (2014) Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer. J Am Soc Echocardiogr 27:83-92. doi:10.1016/j.echo.2013.10.008
18. Negishi K, Negishi T, Haluska BA, Hare JL, Plana JC, Marwick TH (2013) Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection. Eur Heart J Cardiovasc Imaging 15(3):324-331
19. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-1463. doi:10.1016/j.echo. 2005.10.005 (Pubitemid 41821197)
20. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelisa A (2009) Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 10:165-193. doi:10.1093/ejechocard/jep007
21. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450-458 (Pubitemid 16119719)
22. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA (1997) Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527-1533 (Pubitemid 27486472)
23. Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M, Kaluski E, Krakover R, Vered Z (2004) Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 17:1021-1029. doi:10.1016/j.echo.2004.06.019 (Pubitemid 39273478)
24. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539-542 (Pubitemid 34262671)
25. Berne RM, Levy MN (1993) Physiology. Mosby, St. Louis
26. Dalen H, Thorstensen A, Aase SA, Ingul CB, Torp H, Vatten LJ, Stoylen A (2010) Segmental and global longitudinal strain and strain rate based on echocardiography of 1266 healthy individuals: the HUNT study in Norway. Eur J Echocardiogr 11:176-183. doi:10.1093/ejechocard/jep194
27. Hess G, Runkel S, Zdunek D, Hitzler WE (2005) Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): a study in blood donors. Clin Chim Acta 360:187-193. doi:10.1016/j.cccn.2005.04.031 (Pubitemid 41225411)
28. Ho E, Brown A, Barrett P, Morgan RB, King G, Kennedy MJ, Murphy RT (2010) Subclinical anthracycline- and trastuzumabinduced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart 96:701-707. doi:10.1136/hrt.2009.173997
29. Migrino RQ, Aggarwal D, Konorev E, Brahmbhatt T, Bright M, Kalyanaraman B (2008) Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography. Ultrasound Med Biol 34:208-214. doi:10.1016/j. ultrasmedbio.2007.07.018
30. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Cohen V, Gosavi S, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M (2011) Early detection and prediction of cardiotoxicity in che-motherapy-treated patients. Am J Cardiol 107:1375-1380. doi:10.1016/j.amjcard.2011.01.006
31. Risum N, Ali S, Olsen NT, Jons C, Khouri MG, Lauridsen TK, Samad Z, Velazquez EJ, Sogaard P, Kisslo J (2012) Variability of global left ventricular deformation analysis using vendor dependent and independent two-dimensional speckle-tracking software in adults. J Am Soc Echocardiogr 25:1195-1203. doi:10.1016/j.echo.2012.08.007
32. Telli ML, Hunt SA, Carlson RW, Guardino AE (2007) Trast-uzumab-related cardiotoxicity: calling into question the concept of reversibility. J Clin Oncol 25:3525-3533. doi:10.1200/JCO.2007.11.0106 (Pubitemid 47310891)
33. Hare JL, Brown JK, Leano R, Jenkins C, Woodward N, Marwick TH (2009) Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. Am Heart J 158:294-301. doi:10.1016/j.ahj.2009.05.031
34. Giantris A, Abdurrahman L, Hinkle A, Asselin B, Lipshultz SE (1998) Anthracycline-induced cardiotoxicity in children and young adults. Crit Rev Oncol Hematol 27:53-68 (Pubitemid 28275509)
35. Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, Gelber RD, Colan SD (2005) Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23:2629-2636. doi:10.1200/JCO.2005.12.121 (Pubitemid 46179451)
36. Steinherz LJ, Steinherz PG, Tan C (1995) Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. Med Pediatr Oncol 24:352-361
37. Bernaba BN, Chan JB, Lai CK, Fishbein MC (2010) Pathology of late-onset anthracycline cardiomyopathy. Cardiovasc Pathol 19:308-311. doi:10.1016/j. carpath.2009.07.004
38. Shapiro CL, Hardenbergh PH, Gelman R, Blanks D, Hauptman P, Recht A, Hayes DF, Harris J, Henderson IC (1998) Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol 16:3493-3501 (Pubitemid 28506759)
39. Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, Peto R, Baum M, Fisher B, Host H et al (1994) Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12:447-453 (Pubitemid 24079884)
40. Erven K, Florian A, Slagmolen P, Sweldens C, Jurcut R, Wildiers H, Voigt JU, Weltens C (2012) Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2012.09.022
41. Malhotra V, Dorr VJ, Lyss AP, Anderson CM, Westgate S, Reynolds M, Barrett B, Perry MC (2004) Neoadjuvant and adjuvant chemotherapy with doxorubicin and docetaxel in locally advanced breast cancer. Clin Breast Cancer 5:377-384 (Pubitemid 40109646)
42. Aihara T, Takatsuka Y, Itoh K, Sasaki Y, Katsumata N, Watanabe T, Noguchi S, Horikoshi N, Tabei T, Sonoo H, Hiraki S, Inaji H (2003) Phase II study of concurrent administration of doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancer. Oncology 64:124-130 (Pubitemid 36173377)
43. Gamucci T, D'Ottavio AM, Magnolfi E, Barduagni M, Vaccaro A, Sperduti I, Moscetti L, Belli F, Meliffi L (2007) Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer. Br J Cancer 97:1040-1045. doi:10.1038/sj.bjc.6603982 (Pubitemid 47587004)
44. Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth A, Ziegler J (1981) Cardiotoxicity associated with highdose cyclophosphamide therapy. Arch Intern Med 141: 758-763 (Pubitemid 11120879)
45. Braverman AC, Antin JH, Plappert MT, Cook EF, Lee RT (1991) Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol 9:1215-1223
46. Horacek JM, Pudil R, Jebavy L, Tichy M, Zak P, Maly J (2007) Assessment of anthracycline-induced cardiotoxicity with biochemical markers. Exp Oncol 29:309-313 (Pubitemid 351236322)
47. Romano S, Fratini S, Ricevuto E, Procaccini V, Stifano G, Mancini M, Di Mauro M, Ficorella C, Penco M (2011) Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients. Br J Cancer 105:1663-1668. doi:10.1038/bjc.2011.439